You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adalimumab

Showing 1 - 25 of 218
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)

Not yet recruiting
  • Inflammatory Arthritis
  • Immune-related Adverse Event
  • (no location specified)
Sep 13, 2023

Therapeutic Monitoring of Infliximab and Adalimumab

Recruiting
  • Inflammatory Bowel Diseases
  • Trieste, Italy
    IRCCS Burlo Garofolo
Sep 5, 2023

Healthy Volunteers Trial (ABP 501, Adalimumab)

Completed
  • Healthy Volunteers
  • ABP 501
  • Adalimumab
  • (no location specified)
Aug 9, 2023

Juvenile Psoriatic Arthritis Trial (Adalimumab, Risankizumab)

Not yet recruiting
  • Juvenile Psoriatic Arthritis
  • (no location specified)
Oct 20, 2023

Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)

Not yet recruiting
  • Crohn's Disease
  • Chicago, Illinois
    University of Chicago Medicine
Sep 13, 2023

Healthy Trial in Merksem (Adalimumab, Lipopolysaccharide (LPS))

Recruiting
  • Healthy
  • Adalimumab
  • Lipopolysaccharide (LPS)
  • Merksem, Belgium
    Clinical Pharmacology Unit
May 22, 2023

Behcet's Uveitis Trial (Adalimumab, Tocilizumab)

Not yet recruiting
  • Behcet's Uveitis
  • (no location specified)
May 15, 2023

Plaque Psoriasis Trial in Russian Federation (Adalimumab, Humira)

Not yet recruiting
  • Plaque Psoriasis
  • Barnaul, Russian Federation
  • +8 more
Aug 21, 2023

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

Recruiting
  • Vogt-Koyanagi-Harada Disease
  • Adalimumab
  • Adalimumab
  • Tianjin, Tianjin, China
    Tianjin Medical University Eye Hospital
Oct 19, 2022

Adalimumab Withdrawal or Continuation on Severity of COVID-19

Completed
  • Inflammatory Bowel Diseases
  • Rheumatic Disorder
  • Adalimumab
  • Milano, Italy
    Irccs Ospedale San Raffaele
Jan 30, 2023

Yuflyma® (Adalimumab), Patient Experience After Switching

Recruiting
  • Rheumatoid Arthritis
  • +5 more
  • Adalimumab
  • Marseille, France
  • +1 more
Jun 17, 2022

Application of N-of-1 Rheumatoid Arthritis

Not yet recruiting
  • Arthritis, Rheumatoid
  • Adalimumab
  • +2 more
  • Boston, Massachusetts
    Tufts Medical Center
Aug 24, 2023

Non-infectious Intermediate Posterior- or Pan-uveitis Trial in China (Adalimumab)

Recruiting
  • Non-infectious Intermediate Posterior- or Pan-uveitis
  • Adalimumab
  • Beijing, Beijing, China
  • +7 more
Dec 6, 2022

Immune System Disorder Trial in Chang Chun (HLX03, adalimumab)

Completed
  • Immune System Disorder
  • Chang Chun, Jilin, China
    the 1st affiliated hospital of Jilin University
May 4, 2022

Irritable Bowel Disease Trial in Cairo (Infliximab, Adalimumab)

Recruiting
  • Irritable Bowel Disease
  • Cairo, Egypt
    Tropical Medicine department, Ain Shams University Hospitals.
Mar 12, 2022

Mild to Moderate COVID-19 Trial (Adalimumab, Placebo)

Withdrawn
  • Mild to Moderate COVID-19
  • Adalimumab
  • Placebo
  • (no location specified)
Mar 2, 2022

Plaque Psoriasis Trial in Beijing (HLX03, adalimumab)

Completed
  • Plaque Psoriasis
  • Beijing, China
    Peking University People's Hospital
May 4, 2022

Benign Prostatic Hyperplasia (BPH) Trial in Glenview (Adalimumab)

Not yet recruiting
  • Benign Prostatic Hyperplasia (BPH)
  • Adalimumab
  • Glenview, Illinois
    NorthShore University HealthSystem
Sep 25, 2023

Uveitis Trial in Spain (Methotrexate, Adalimumab, Adalimumab+Methotrexate)

Recruiting
  • Uveitis
  • A Coruña, Spain
  • +13 more
Mar 15, 2022

Crohn's Disease Trial in Petach Tikva (Adalimumab)

Completed
  • Crohn's Disease
  • Adalimumab
  • Petach Tikva, Israel
    Schneider Children's Hospital
Sep 25, 2021

Diabetes, Type 1, Hypoglycemia, Autoimmune Diseases Trial in Miami (Anti-Thymocyte Globulin (ATG), Interleukin 2, Exenatide)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +3 more
  • Anti-Thymocyte Globulin (ATG)
  • +7 more
  • Miami, Florida
    Diabetes Research Institute, University of Miami Miller School o
Feb 23, 2022

Psoriasis Trial (risankizumab, adalimumab, for risankizumab)

Completed
Has Results
  • Psoriasis
  • (no location specified)
Jul 28, 2021

Arthritis, Psoriatic Trial in Bulgaria, Poland, United States (Sonelokimab, Placebo, Adalimumab)

Recruiting
  • Arthritis, Psoriatic
  • Rancho Mirage, California
  • +10 more
Jan 24, 2023

IBD Trial in Madrid (Adalimumab)

Recruiting
  • Inflammatory Bowel Diseases
  • Adalimumab
  • Madrid, Madrd, Spain
    Hospital Universitario La Paz
Jul 22, 2021

Crohn's Disease Trial (BT-11 (Omilancor), adalimumab)

Withdrawn
  • Crohn's Disease
  • BT-11 (Omilancor)
  • adalimumab
  • (no location specified)
Mar 10, 2022